The Ministry of Chemicals and Fertilizers on 26th July 2022, has invited Applications for the eligible product Vitamin B1, through chemical synthesis route under the Production Linked Incentive (PU) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country. PLI Scheme for Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) was notified on 20th July, 2020. The Financial incentive under the sub-scheme is provided on the sales of 41 identified products categorized into four Target Segments.
Under this Scheme, the Eligible Product ‘Vitamin B1’ was categorised under the head‘Fermentation based niche KSMs/ Drug Intermediaries/ APIs’ and applications were invited accordingly. However, representations were received subsequently that the Vitamin B1 can be manufactured through chemical synthesis route also. Therefore, the classification of the Eligible Product: ‘Vitamin B1’ has been changed to ‘Other Chemical Synthesis based KSMs/ Drug Intermediaries/ APIs’.
Applications are being invited for Vitamin B1 under the category ‘Other Chemical Synthesis based KSMs/ Drug Intermediaries/ APIs’. The rate of incentive has accordingly been revised to FY 2023 -24 to FY 2027-28-10 %, instead of earlier rate of FY 2023-24 to FY 2026-27: 20%, FY 2027-28: 15 %, FY 2028-29: 5 %. Eligible applicants may apply through online mode only at https://plibulkdrugs.ifciltd.com. The last date of filing the application is 24th August, 2022.
